Washington Trust Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.57K Buy
+90
New +$10.9K ﹤0.01% 527
2025
Q4
– Sell
-33
Closed -$4.75K – 634
2025
Q3
$4.75K Sell
33
-75
-69% -$9.19K ﹤0.01% 622
2025
Q2
$10.9K Sell
108
-41
-28% -$3.13K ﹤0.01% 466
2025
Q1
$11.4K Hold
149
– – ﹤0.01% 453
2024
Q4
$10.3K Hold
149
– – ﹤0.01% 475
2024
Q3
$10.9K Hold
149
– – ﹤0.01% 468
2024
Q2
$9.98K Sell
149
-62
-29% -$2.4K ﹤0.01% 466
2024
Q1
$5.72K Hold
211
– – ﹤0.01% 553
2023
Q4
$6.54K Hold
211
– – ﹤0.01% 540
2023
Q3
$5.33K Hold
211
– – ﹤0.01% 544
2023
Q2
$4.45K Hold
211
– – ﹤0.01% 561
2023
Q1
$3.6K Hold
211
– – ﹤0.01% 662
2022
Q4
$4.22K Hold
211
– – ﹤0.01% 632
2022
Q3
$5K Hold
211
– – ﹤0.01% 716
2022
Q2
$4K Hold
211
– – ﹤0.01% 784
2022
Q1
$5K Buy
211
+55
+35% +$1.28K ﹤0.01% 816
2021
Q4
$4K Buy
+156
New +$4.46K ﹤0.01% 884

Other funds holding INSM

Washington Trust Advisors's INSM Position: Q2 2026 in Review

Washington Trust Advisors opened a new position in Insmed (INSM) in Q2 2026: 90 shares worth $9.57K. The stake represents ﹤0.01% of the portfolio and ranks #527 among its holdings. This is a return to the name: Washington Trust Advisors previously reported a position in INSM as recently as Q3 2025.

Washington Trust Advisors first reported a position in INSM in Q4 2021 and has held it in 17 quarters since. The position peaked at $11.4K in Q1 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Washington Trust Advisors held 90 shares of Insmed worth $9.57K as of Q2 2026.
  • Insmed was a new Washington Trust Advisors position in Q2 2026.
  • Insmed made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #527 holding.
  • Washington Trust Advisors first reported a position in Insmed in Q4 2021 and has held it in 17 quarters since.
  • Washington Trust Advisors's Insmed position peaked at $11.4K in Q1 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.